openPR Logo
Press release

Pulmonary Edema Market Compressive Growth In Near Future 2023 Years With Top Key Players - Pfizer Inc., ARGON MEDICAL, Edwards Lifesciences Corporation, BD, Alcaliber S.A.

03-14-2019 01:37 PM CET | Health & Medicine

Press release from: Market Research Future

Pulmonary Edema Market Compressive Growth In Near Future 2023

Pulmonary edema market report is a complete overview of the market, covering various aspects product definition, segmentation based on various parameters, and the prevailing vendor landscape. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors.

Market Highlights

Increasing prevalence of pulmonary edema and diseases like kidney failure, heart diseases, and others along with the growing geriatric population boosts the market growth. On the other hand, low per capita healthcare expenditure in the middle and low-income countries, and lack of awareness about the disease are estimated to restrain the market growth.

The global pulmonary edema market is expected to grow at an approximate CAGR of 7.2% during the forecast period.

Offering Free Sample Report: https://www.marketresearchfuture.com/sample_request/5607

Key Players

Lupin Pharmaceuticals, Inc. (India), Vitaltec Corporation (China), Medtronic (U.S.), Koninklijke Philips N.V. (The Netherlands), Siemens Healthcare GmbH (Germany), Hitachi Medical Corporation (U.S.), CANON MEDICAL SYSTEMS CORPORATION (Japan), others.

Segmentation

The global pulmonary edema market is segmented on the basis of type, diagnosis, treatment, and end user.On the basis of the type, the market is segmented into cardiogenic edema, cardiogenic edema, and others. On the basis of the diagnosis, the market is categorized into blood tests, imaging, and others. The blood tests segment is sub-segmented into b-type natriuretic peptide (BNP), blood count test, kidney function test, and others.

The imaging segment is sub-segmented into chest x-ray, electrocardiogram, echocardiogram, transesophageal echocardiography, pulse oximetry, and others. On the basis of the treatment, the market is segmented into preload reducers, morphine, suction catheter, and others. The preload reducers segment is sub-segmented into nitroglycerin, diuretics, and others. On the basis of the end users, the market is segmented into hospitals & clinics, academic institutes, retail pharmacies, and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/pulmonary-edema-market-5607

Regional Analysis

America dominates the global pulmonary edema market due to the presence of a well-developed healthcare sector, high per capita healthcare expenditure and developed economies such as the U.S. and Canada within the region. Additionally, global players such as Pfizer Inc., Edwards Lifesciences Corporation, ARGON MEDICAL, and others within the region boost the market. Europe holds the second major market for pulmonary edema, followed by the Asia Pacific owing to the availability of funds for research and presence of developed economies like France, Italy, and Germany within the region along with the growing geriatric population.

Asia Pacific is the fastest growing region for the global pulmonary edema market due to rising healthcare expenditure, favorable government policies, and huge patient population. The Middle East & Africa has the least share in the global pulmonary edema market.  Presence of poor economies and stringent government policies especially within in the African region retains the regional market growth. A majority of the market in the region is held by the Middle East due to huge healthcare expenditure and presence of developed healthcare sector.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Edema Market Compressive Growth In Near Future 2023 Years With Top Key Players - Pfizer Inc., ARGON MEDICAL, Edwards Lifesciences Corporation, BD, Alcaliber S.A. here

News-ID: 1654635 • Views:

More Releases from Market Research Future

Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
Glue Machine Market to Reach USD 14.9 Billion by 2035, Growing at 4.56% CAGR
The Glue Machine Market is witnessing significant growth due to the increasing adoption of adhesive technologies across various industries, including packaging, woodworking, automotive, furniture, and construction. Valued at USD 9.15 billion in 2024, the market is projected to reach USD 14.9 billion by 2035, registering a CAGR of 4.56% between 2025 and 2035. Glue machines, also known as adhesive application machines, are critical for efficiently dispensing adhesives in industrial and commercial
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
Expansion Valves Market to Reach USD 5.39 Billion by 2035, Growing at 4.62% CAGR
The expansion valves market is witnessing steady growth due to increasing demand for efficient heating, ventilation, air conditioning, and refrigeration (HVACR) systems across residential, commercial, and industrial sectors. Valued at USD 3.28 billion in 2024, the market is projected to reach USD 5.39 billion by 2035, growing at a CAGR of 4.62% between 2025 and 2035. Expansion valves, also known as thermostatic expansion valves (TXVs) or electronic expansion valves (EEVs), are
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CAGR
Cheese Packaging Market to Reach USD 101.31 Billion by 2034, Growing at 3.50% CA …
The Cheese Packaging Market is poised for steady growth over the next decade due to rising demand for dairy products, evolving consumer preferences, and increasing focus on food safety and sustainability. According to recent estimates, the market was valued at USD 71.87 billion in 2024 and is projected to reach USD 101.31 billion by 2034, growing at a compound annual growth rate (CAGR) of 3.50% between 2025 and 2034. Cheese packaging
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
Maritime Market to Reach USD 2,920 Billion by 2035, Growing at 2.69% CAGR
The Maritime Market is a cornerstone of international trade, logistics, and economic connectivity, serving as the backbone of global commerce. Valued at USD 2,181.1 billion in 2024, the market is projected to expand to USD 2,920 billion by 2035, registering a steady CAGR of 2.69% between 2025 and 2035. Despite modest growth, the industry's scale and importance are unmatched, as more than 80% of global trade volume is carried by

All 5 Releases


More Releases for Pulmonary

Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments